Rousian, M.
van Verschuer, V.
Franssen, S.
Bijdevaate, D.
Bokkers, R. P.H.
Braat, A. E.
de Bruijne, J.
Bruno, M. J.
Burgmans, M. C.
van Delden, O. M.
Dewulf, M.
Erdmann, J. I.
Hagendoorn, J.
van der Holt, B.
Hoogwater, F. J.H.
Inderson, A.
van der Leij, C.
Mohseny, B.
Poley, J. W.
Smits, M. L.J.
van Vilsteren, F. G.I.
Voermans, R. P.
Zijlstra, I. A.J.
van Driel, L. M.J.W.
Koerkamp, B. Groot
Article History
Received: 3 April 2025
Accepted: 15 April 2025
First Online: 9 May 2025
Declarations
:
: This study was approved by the Medical Ethics Committee (METC) of Erasmus Medical Center, Rotterdam, under approval number MEC-2023-0200. All procedures were conducted in accordance with the Declaration of Helsinki and local ethical guidelines.
: The TESLA RCT opened for accrual on May 12, 2023, and the first patient was randomized on August 9, 2023. As of April 18, 2025, 4 participating Dutch centers are open for inclusion and 67 patients have been randomized.
: The authors declare no competing interests.